Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 048876/0682 | |
| Pages: | 10 |
| | Recorded: | 04/11/2019 | | |
| Attorney Dkt #: | 26156 |
| Conveyance: | CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
9
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14401899
|
Filing Dt:
|
11/18/2014
|
|
Publication #:
|
|
Pub Dt:
|
05/14/2015
| | | | |
|
Title:
|
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/21/2018
|
Application #:
|
15227565
|
Filing Dt:
|
08/03/2016
|
|
Publication #:
|
|
Pub Dt:
|
11/17/2016
| | | | |
|
Title:
|
ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/17/2018
|
Application #:
|
15231185
|
Filing Dt:
|
08/08/2016
|
|
Publication #:
|
|
Pub Dt:
|
11/24/2016
| | | | |
|
Title:
|
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15448831
|
Filing Dt:
|
03/03/2017
|
|
Publication #:
|
|
Pub Dt:
|
08/24/2017
| | | | |
|
Title:
|
GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/11/2019
|
Application #:
|
15684168
|
Filing Dt:
|
08/23/2017
|
|
Publication #:
|
|
Pub Dt:
|
01/04/2018
| | | | |
|
Title:
|
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF PANCREATIC CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/11/2020
|
Application #:
|
15710252
|
Filing Dt:
|
09/20/2017
|
|
Publication #:
|
|
Pub Dt:
|
05/10/2018
| | | | |
|
Title:
|
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15909577
|
Filing Dt:
|
03/01/2018
|
|
Publication #:
|
|
Pub Dt:
|
09/13/2018
| | | | |
|
Title:
|
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/27/2020
|
Application #:
|
15973116
|
Filing Dt:
|
05/07/2018
|
|
Publication #:
|
|
Pub Dt:
|
11/15/2018
| | | | |
|
Title:
|
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/07/2024
|
Application #:
|
16037759
|
Filing Dt:
|
07/17/2018
|
|
Publication #:
|
|
Pub Dt:
|
11/08/2018
| | | | |
|
Title:
|
ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
|
|
|
Assignee
|
|
|
|
|
| AN DER GOLDGRUBE 12 |
| MAINZ, GERMANY 55131 |
|
|
Correspondence name and address
|
| |
NEAL, GERBER & EISENBERG LLP
|
| |
TWO NORTH LASALLE STREET
|
| |
SUITE 1700
|
| |
CHICAGO, IL 60602
|
Search Results as of:
06/20/2024 01:20 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
